Lani or others following the SABCS Posters

[alw]

To anyone reviewing the posters for the upcoming SABCS Conference - or anyone else in the know,

I've been looking for a poster for the results of the Phase III GSK Clinical Trial involving combining Herceptin and Lapatinib (EGF104900). It doesn't appear to be on the schedule.

Just thought I'd throw this out there in case anyone has an inside source.

With warm regards,

Amy

[Joe]

Amy,
We have a meeting scheduled with GSK in San Antonio and will certainly bring that up.

Regards
Joe

[alw]

Hello,

I was wondering if anyone was able to learn anything regarding the GSK Phase III trial combining Herceptin and Tykerb (http://clinicaltrials.gov/ct2/show/NCT00320385?term=lapatinib+trastuzumab&rank=10)?

It was a larger study (270) and began in Nov 2005. Clinicaltrials.gov indicates that it is ongoing but not recruiting. Some GSK literature indicated that preliminary results would be available Quarter 3 of 2007.

I know that Nancy Lin at Dana Farber has a current Phase II study (NCT00470704) that started in May of 2007.

And there are a number of others that are new or not yet started that include Herceptin and/or Tykerb plus a Taxol or other agent.

Any insider information would be greatly appreciated.

Regards,

Amy

[Lani]

Sorry. Did anyone else? Lani

[Lani]

navigates to it from www.sabcs.org refers briefly to the trials, no results yet
Also discusses excellent preclinical synergism.